Literature DB >> 7761094

Mutant alpha subunit of Gz transforms Swiss 3T3 cells.

Y H Wong1, J S Chan, L Y Yung, H R Bourne.   

Abstract

Many hormones and neurotransmitters induce cell proliferation by regulating signaling pathways controlled by heterotrimeric G proteins. Mutations that activate the alpha subunits of Gs and Gi2 produce the gsp and gip2 oncogenes that are found in certain human endocrine tumors. Similar mutations have conferred on other G alpha subunits the ability to promote neoplastic transformation in cultured mammalian cells. Gz, a G protein whose normal signaling function is poorly understood, shares with Gi2 the ability to inhibit adenylyl cyclase. We asked whether mutationally activated alpha z can stimulate cell proliferation in a cell line in which stimulation adenylyl cyclase is mitogenic, Swiss 3T3 cells. Stable expression of alpha z-Q205L in Swiss 3T3 cells induced focus formation, a faster growth rate with a higher saturation density, anchorage-independent growth in soft agar, and increased [3H]thymidine incorporation in the absence of growth factors. alpha z-Q205L produced a similar but less extensively transformed phenotype in NIH3T3 cells--increased saturation density in culture, a smaller number of foci and few colonies in soft agar. Stimulation of thymidine incorporation by alpha z-Q205L in Swiss 3T3 cells was increased by co-treatment with cholera toxin, a stimulator of adenylyl cyclase. Taken together, our results indicate that alpha z stimulates one or more mitogenic pathways in Swiss 3T3 cells, and that effectiveness of these mitogenic pathways does not require reducing the concentration of cellular cAMP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7761094

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

Review 1.  Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins.

Authors:  T A Fields; P J Casey
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

2.  Different biochemical properties explain why two equivalent Gα subunit mutants cause unrelated diseases.

Authors:  Anthony Leyme; Arthur Marivin; Jason Casler; Lien T Nguyen; Mikel Garcia-Marcos
Journal:  J Biol Chem       Date:  2014-06-30       Impact factor: 5.157

3.  Molecular basis of a novel oncogenic mutation in GNAO1.

Authors:  M Garcia-Marcos; P Ghosh; M G Farquhar
Journal:  Oncogene       Date:  2011-02-14       Impact factor: 9.867

4.  Probing the mutational landscape of regulators of G protein signaling proteins in cancer.

Authors:  Vincent DiGiacomo; Marcin Maziarz; Alex Luebbers; Jillian M Norris; Pandu Laksono; Mikel Garcia-Marcos
Journal:  Sci Signal       Date:  2020-02-04       Impact factor: 8.192

5.  Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression.

Authors:  David C New; Yung H Wong
Journal:  J Mol Signal       Date:  2007-02-26

Review 6.  Clinical potential of the Hippo-YAP pathway in bladder cancer.

Authors:  Xin Cheng; Kecheng Lou; Liang Ding; Xiaofeng Zou; Ruohui Huang; Gang Xu; Junrong Zou; Guoxi Zhang
Journal:  Front Oncol       Date:  2022-07-15       Impact factor: 5.738

7.  Naturally occurring hotspot cancer mutations in Gα13 promote oncogenic signaling.

Authors:  Marcin Maziarz; Anthony Federico; Jingyi Zhao; Lorena Dujmusic; Zhiming Zhao; Stefano Monti; Xaralabos Varelas; Mikel Garcia-Marcos
Journal:  J Biol Chem       Date:  2020-10-27       Impact factor: 5.486

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.